Last reviewed · How we verify
AC01
At a glance
| Generic name | AC01 |
|---|---|
| Sponsor | AnaCardio AB |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phase Ib/IIa Trial With AC01 in Patients With HFrEF (PHASE1,PHASE2)
- Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |